Featured
China's growth and it's implications
Vanguard's proprietary measure reflects volatility in growth that doesn't appear in official GDP numbers.
Why talk about a market downturn now? Why not?
With stock markets near record highs and uncertainty all around, it's a good time to speak about the value of long-term investing.
Vanguard economic and market update - January 2021
In the United States, a more recent trend of daily COVID-19 vaccinations approaching 1 million reaffirms our outlook for GDP growth above 5% in 2021. Additional fiscal stimulus would introduce the potential for further upside to growth.
For now, policy remains a tailwind
Amid hope that COVID-19 vaccines drive immunity and enliven economic activity, investors are starting to wonder what happens when 'whatever it takes' fiscal and monetary policy gives way to an unwinding of bold actions. But that may not happen anytime soon.
Spotlight Voice
Inna Zorina is a Senior Investment Strategist for Vanguard Australia.
COVID-19 vaccine rollout and the economy
The pace of vaccinations holds the key to achieving COVID-19 herd immunity and to economic recovery.
When stocks get ahead of fundamentals
Recent market events underscore the importance of a long-term approach to investing.
Mirage of Stability: China's True Economic Growth
Vanguard analysis shows that alternative measures form a clearer picture of China's true economic growth.
Emerging-market debt: Finding value in a time of pandemic
Vanguard's emerging markets credit team believes opportunities to add value exist even in this rapidly evolving fiscal environment.
U.S. equities outperformed their international counterparts by 8 percentage points per year on average over the 10 years ended December 31, 2019. However, our proprietary Vanguard Capital Markets Model (VCMM) suggests that this outperformance is unlikely to persist over the next 10 years.
Vanguard economic and market outlook for 2021: Approaching the dawn
While the global economy continues to recover as we head into 2021, the battle between the virus and humanity's efforts to stanch it continues.
Vanguard economic and market update - November 2020
Based on promising signs that COVID-19 vaccines currently in trail are effectiveand production capacity allows for doses to be delivered early-to-mid-2021, Vanguardsees an increased likelihood of the U.S. economy reaching pre-COVID-19 output levelsbefore the end of 2021.
Quantifying the future of remote work
A Vanguard analysis finds that about 15% of all U.S. jobs can permanently be performed remotely.
A pandemic, a vaccine, and a sea of ideas
We're not surprised that a COVID-19 vaccine came this far so quickly. It was a decade of idea-sharing in the making.
Active Fixed Income Perspectives - September quarter 2020
Beyond the uncertainty surrounding the ongoing global Covid-19 pandemic, we see room for market volatility to increase heading into year-end. The US election, a stalled US fiscal relief package and complications around Brexit all have the potential to weigh on investor sentiment and move market prices.
Hear directly from Vanguard leaders on topics you care about
Vanguard Voicesâ„¢